Compare IRWD & KE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRWD | KE |
|---|---|---|
| Founded | 1998 | 1961 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 687.4M | 564.2M |
| IPO Year | 2009 | 2014 |
| Metric | IRWD | KE |
|---|---|---|
| Price | $3.76 | $28.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $6.10 | ★ $34.25 |
| AVG Volume (30 Days) | ★ 1.5M | 140.1K |
| Earning Date | 11-09-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1400.00 | 66.18 |
| EPS | 0.55 | ★ 1.13 |
| Revenue | $298,276,000.00 | ★ $1,431,378,000.00 |
| Revenue This Year | $59.19 | $7.92 |
| Revenue Next Year | $4.80 | $4.15 |
| P/E Ratio | ★ $7.49 | $24.57 |
| Revenue Growth | ★ 8.88 | N/A |
| 52 Week Low | $1.41 | $21.60 |
| 52 Week High | $5.78 | $32.00 |
| Indicator | IRWD | KE |
|---|---|---|
| Relative Strength Index (RSI) | 40.20 | 62.40 |
| Support Level | $3.89 | $23.59 |
| Resistance Level | $3.96 | $28.00 |
| Average True Range (ATR) | 0.19 | 0.90 |
| MACD | -0.04 | 0.22 |
| Stochastic Oscillator | 7.28 | 78.18 |
Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.
Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.